EMDR Pre-treatment Yoga for Complex Trauma

ConditionTrauma, Psychological

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18-70

SponsorDominique JANUEL

About this trial

yoga is a technique of hope. Indeed, it is a practice that specifically combines postures, breathing technique and a state meditative. The combination of these elements produces multiple effects that are exposed to detailed in the publications of Bessel Van der Kolk (Price et al., 2017; Rhodes, Spinazzola, \& van der Kolk, 2016; Van der Kolk, 2014; Van Der Kolk et al., 2014) and whose four main effects are summarized here:

* A regulation of the level of vigilance * An improvement in self-awareness * An increased sense of self-efficacy * Improved metacognition, awareness and regulation emotional

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Meets diagnostic criteria for Complex Post-traumatic Stress Disorder according to ICD-11 criteria, related to childhood sexual abuse

PCL-5 must be at least 45

Age between 18 and 70.

Free, informed and signed consent.

Disqualifiers

Pregnant women

Severe and/or unstable somatic diseases

Diseases resulting in serious motor disorders (e.g. people paralyzed)

Patient not affiliated with social security, State Medical Aid (AME)

Trial design

Design model

Parallel

Treatments tested in this trial

10 Sessions of yogatherapy associate with EMDR
Other intervention
The first group will have Yogatherapy plus EMDR treatment
The second group will have EMDR without yogatherapy
Other intervention
the second one will have EMDR treatment

Treatment groups

66 Participants

are divided into 2 treatment groups

Group A: yogatherapy-EMDRActive comparator 1 intervention

Group B: waiting list and EMDRActive comparator 1 intervention

Trial outcomes

Primary outcomes

PCL-5: Scale of post-traumatic stress disorder

PTSD Scale : Evaluation of clinical symptomatology and severity of PTSD

Time frame

first week

PCL-5: Scale of post-traumatic stress disorder

PTSD Scale : Evaluation of clinical symptomatology and severity of PTSD

Time frame

At twenty week

Secondary outcomes

CAPS-5: PTSD Scale Administered by Clinician

Evaluation of clinical symptomatology and severity of PTSD Diagnosis of comorbidities

Time frame

First week

CAPS-5: PTSD Scale Administered by Clinician

Evaluation of clinical symptomatology and severity of PTSD Diagnosis of comorbidities

Time frame

At ten week

CAPS-5: PTSD Scale Administered by Clinician

Evaluation of clinical symptomatology and severity of PTSD Diagnosis of comorbidities

Time frame

At twenty week

Other outcomes

CGI : Clinical global Impression

Evaluation of overall clinical improvement.

Time frame

At first week

CGI : Clinical global Impression

Evaluation of overall clinical improvement.

Time frame

At ten week

CGI : Clinical global Impression

Evaluation of overall clinical improvement.

Time frame

At twenty week

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Dominique JANUEL

Lead sponsor

Centre hospitalier de Ville-Evrard, France

Sponsor institution

Source ClinicalTrials.gov

Apply now